Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues-Reference-Cited by-同舟云学术

Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues

Published:2020-10-15 Issue:8 Volume:20 Page:1133-1143
ISSN:1871-5303
Container-title:Endocrine, Metabolic & Immune Disorders - Drug Targets
language:en
Short-container-title:EMIDDT

Author:

Cozzi Renato¹^ORCID,Ambrosio Maria R.²^ORCID,Attanasio Roberto³^ORCID,Bozzao Alessandro⁴^ORCID,De Marinis Laura⁵,De Menis Ernesto⁶,Guastamacchia Edoardo⁷,Lania Andrea⁸^ORCID,Lasio Giovanni⁹^ORCID,Logoluso Francesco¹⁰,Maffei Pietro¹¹,Poggi Maurizio¹²,Toscano Vincenzo¹²^ORCID,Zini Michele¹³,Chanson Philippe¹⁴^ORCID,Katznelson Laurence¹⁵^ORCID

Affiliation:

1. Division of Endocrinology, Niguarda Hospital, Milan, Italy

2. Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy

3. IRCCS Orthopedic Institute Galeazzi, Endocrinology Service, Milan, Italy

4. Neuroradiology, S. Andrea Hospital, NESMOS Department (Neuroscience, Mental Health, Sensorial Organs), Sapienza University of Rome, Rome, Italy

5. Pituitary Unit, Department of Endocrinology, Catholic University of the Sacred Heart, School of Medicine, Rome, Italy

6. Department of Internal Medicine, General Hospital, Montebelluna (TV), Italy

7. AME President, University of Bari, Bari, Italy

8. Department of Biomedical Sciences, IRCCS Humanitas University and Endocrinology Unit, Humanitas Research Hospital, Rozzano, Italy

9. Department of Neurosurgery, Humanitas University and Endocrinology Unit, Humanitas Research Hospital, Rozzano, Italy

10. Endocrinology Unit, Department of Emergency and Organ Transplantation, University Medical School 'Aldo Moro', Bari, Italy

11. Department of Medicine (DIMED), 3rd Medical Clinic, Padua University Hospital, Padua, Italy

12. Endocrinology, Department of Clinical and Molecular Medicine, S. Andrea Hospital, Sapienza University of Rome, Rome, Italy

13. Endocrinology Unit, Azienda Ospedaliera S. Maria Nuova IRCCS, Reggio Emilia, Italy

14. Endocrinology and Reproductive Diseases, Bicêtre Hospital and Paris-Saclay University 11, France

15. Department of Medicine, Stanford University Hospital, Stanford, CA, United States

Abstract

Acromegaly is a rare disease. Improvements in lifespan in these patients have recently been reported due to transsphenoidal surgery (TSS), advances in medical therapy, and strict criteria for defining disease remission. This document reports the opinions of a group of Italian experts who have gathered together their prolonged clinical experience in the diagnostic and therapeutic challenges of acromegaly patients. Both GH and IGF-I (only IGF-I in those treated with Pegvisomant) are needed in the diagnosis and follow-up. Comorbidities (cardio-cerebrovascular disease, sleep apnea, metabolic derangement, neoplasms, and bone/joint disease) should be specifically addressed. Any newly diagnosed patient should be referred to a multidisciplinary team experienced in the treatment of pituitary adenomas.

Publisher

Bentham Science Publishers Ltd.

Subject

Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference93 articles.

1. Cozzi R.; Baldelli R.; Colao A.; Lasio G.; Zini M.; Attanasio R.; Chanson P.; Giustina A.; Ghigo E.; Strasburger C.; Italian Association of Clinical Endocrinologists (AME). AME Position Statement on clinical management of acromegaly. J Endocrinol Invest [no LoE].2009,32(Suppl. 6),2-25

2. Atkins D.; Best D.; Briss P.A.; Eccles M.; Falck-Ytter Y.; Flottorp S.; Guyatt G.H.; Harbour R.T.; Haugh M.C.; Henry D.; Hill S.; Jaeschke R.; Leng G.; Liberati A.; Magrini N.; Mason J.; Middleton P.; Mrukowicz J.; O’Connell D.; Oxman A.D.; Phillips B.; Schünemann H.J.; Edejer T.; Varonen H.; Vist G.E.; Williams J.W.; Zaza S.; GRADE Working Group Grading quality of evidence and strength of recommendations. BMJ [no LoE].2004,328(7454),1490-1497

3. Swiglo B.A.; Murad M.H.; Schünemann H.J.; Kunz R.; Vigersky R.A.; Guyatt G.H.; Montori V.M.; A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab [no LoE].2008,93(3),666-673

4. Guyatt G.H.; Oxman A.D.; Vist G.E.; Kunz R.; Falck-Ytter Y.; Alonso-Coello P.; Schünemann H.J.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ [no LoE].2008,336(7650),924-926

5. Fernandez A.; Karavitaki N.; Wass J.A.; Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) [no LoE].2010,72(3),377-382

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acromegalia e gravidanza: gestione clinica;L'Endocrinologo;2024-06

2. The Risk of Neurodegenerative Diseases in Patients With Acromegaly: A Cohort Study;Neurology;2022-10-03

3. The biochemical diagnosis of acromegaly: revising the role of measurement of IGF-I and GH after glucose load in 5 questions;Expert Review of Endocrinology & Metabolism;2022-04-29

4. Oral Manifestations and Maxillo-Facial Features in the Acromegalic Patient: A Literature Review;Journal of Clinical Medicine;2022-02-18

5. The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study;Pituitary;2021-09-13